relmacabtagene autoleucel
jw pharmaceuticals
['carteyva', 'relmacabtagene']
jw therapeutics presented the latest clinical data for carteyva [relmacabtagene autoleucel (relma-cel) injection], a cd19 car-t therapy for adult patients with rr/r fl and r/r mcl at #ash22 . 
Research Intelligence, PharmaDJ, focus on China pharma & biotech industry and investment